Published in Eur J Cancer on October 01, 1995
Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol (2012) 0.98
Incidence of primary malignant orbital tumours in the Netherlands. Eye (Lond) (2011) 0.94
Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. Br J Cancer (2005) 0.91
Geographic clustering of testicular cancer incidence in the northern part of The Netherlands. Br J Cancer (1999) 0.87
Breast cancer risk among first-generation migrants in the Netherlands. Br J Cancer (2004) 0.83
Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB (Oxford) (2012) 0.82
Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens? Ann Surg Oncol (2015) 0.82
Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst (2014) 0.81
Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands. Br J Cancer (2013) 0.80
Incidence of cancer in the area around Amsterdam Airport Schiphol in 1988-2003: a population-based ecological study. BMC Public Health (2005) 0.77
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
[Breast cancer and the use of the hormones around the menopause]. Ned Tijdschr Geneeskd (2003) 3.86
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Lancet (1994) 2.95
Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol (1990) 2.69
[Cancer incidence in the Schiphol area in 1988-1993]. Ned Tijdschr Geneeskd (1997) 2.68
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol (1999) 2.36
Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study. J Natl Cancer Inst (1996) 2.36
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy]. Ned Tijdschr Geneeskd (2004) 2.06
Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. Br J Ind Med (1990) 2.06
[Passive smoking: an environmental health risk]. Ned Tijdschr Geneeskd (2004) 2.04
[The relationship between health gain and effort in mass screening for breast cancer]. Ned Tijdschr Geneeskd (1997) 1.95
Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol (1994) 1.86
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.68
The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study. Occup Environ Med (2008) 1.63
Epidemiology of neuroendocrine tumours. Neuroendocrinology (2004) 1.59
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer (1998) 1.58
Gender differences in stage-adjusted bladder cancer survival. Urology (2000) 1.55
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) Eur J Cancer (1999) 1.55
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol (2012) 1.54
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
p53 protein overexpression in relation to risk factors for breast cancer. Am J Epidemiol (1996) 1.54
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer (2000) 1.52
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50
Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. Ann Oncol (2012) 1.49
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer (2001) 1.43
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet (2000) 1.42
[Sensible family planning: pitfalls and dilemmas]. Ned Tijdschr Geneeskd (2008) 1.42
Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer (1995) 1.42
[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands]. Ned Tijdschr Geneeskd (2006) 1.42
[Disappointing effectiveness of population screening for cervical cancer]. Ned Tijdschr Geneeskd (1997) 1.39
[Passive smoking and lung cancer: a new report in perspective]. Ned Tijdschr Geneeskd (1997) 1.39
Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer (1997) 1.38
[Prevention of cutaneous melanoma]. Ned Tijdschr Geneeskd (1999) 1.38
Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol (2003) 1.38
[The drawbacks of diagnostic diligence]. Ned Tijdschr Geneeskd (1998) 1.38
Physical activity and breast cancer risk in women aged 20-54 years. J Natl Cancer Inst (2000) 1.38
Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut (2010) 1.38
The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer (1999) 1.34
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol (2012) 1.34
Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol (2001) 1.33
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod (2001) 1.28
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol (2011) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ (1994) 1.27
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer (1991) 1.26
A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer (2009) 1.22
Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19
The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study. BJU Int (2001) 1.18
Cancer survival in European adolescents and young adults. Eur J Cancer (2003) 1.17
Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol (2010) 1.17
[The risk of cancer in the Netherlands]. Ned Tijdschr Geneeskd (2008) 1.16
Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol (2007) 1.14
Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer (2006) 1.14
Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat (1991) 1.13
Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update (2013) 1.13
Cancer in the very elderly Dutch population. Cancer (2000) 1.12
The development of a prognostic score for patients with parotid carcinoma. Cancer (1999) 1.11
Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod (2005) 1.11
Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst (1990) 1.11
Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome. Br J Cancer (2009) 1.10
Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09
Polycyclic aromatic hydrocarbon-DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. Cancer Epidemiol Biomarkers Prev (1995) 1.08
The Stellenbosch University Medical Library slide classification, storage, retrieval, and issue system. Bull Med Libr Assoc (1977) 1.08
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol (1999) 1.05
Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer (2009) 1.05
Population density and childhood leukaemia: results of the EUROCLUS Study. Eur J Cancer (1999) 1.04
Risk factors for childhood acute non-lymphocytic leukemia: an association with maternal alcohol consumption during pregnancy? Cancer Epidemiol Biomarkers Prev (1994) 1.04
Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant (2011) 1.04
Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996. Ann Hematol (1999) 1.04
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur Radiol (2012) 1.03
Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer (1994) 1.02
Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment. J Clin Pathol (2008) 1.02
Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer (2010) 1.01
Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation? Hum Reprod (2006) 1.01
Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study. Gynecol Oncol (1991) 1.01